Ying JM - Search Results

1

EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.

Liang Z, Cheng Y, Chen Y, Hu Y, Liu WP, Lu Y, Wang J, Wang Y, Wu G, Ying JM, Zhang HL, Zhang XC, Wu YL. Liang Z, et al. Among authors: ying jm. Cancer Lett. 2017 Sep 10;403:186-194. doi: 10.1016/j.canlet.2017.06.008. Epub 2017 Jun 19. Cancer Lett. 2017. PMID: 28642172 Review.

2

Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.

Zhang Q, Ying J, Zhang K, Li H, Ng KM, Zhao Y, He Q, Yang X, Xin D, Liao SK, Tao Q, Jin J. Zhang Q, et al. Cancer Lett. 2007 May 8;249(2):220-6. doi: 10.1016/j.canlet.2006.08.019. Epub 2006 Oct 9. Cancer Lett. 2007. PMID: 17029774

3

A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.

Li H, Li J, Su Y, Fan Y, Guo X, Li L, Su X, Rong R, Ying J, Mo X, Liu K, Zhang Z, Yang F, Jiang G, Wang J, Zhang Y, Ma D, Tao Q, Han W. Li H, et al. Oncogene. 2014 Jun 12;33(24):3109-18. doi: 10.1038/onc.2013.282. Epub 2013 Jul 29. Oncogene. 2014. PMID: 23893243

4

Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis.

Zhang Q, Zhang L, Li L, Wang Z, Ying J, Fan Y, Xu B, Wang L, Liu Q, Chen G, Tao Q, Jin J. Zhang Q, et al. Cancer Lett. 2014 Nov 28;354(2):227-34. doi: 10.1016/j.canlet.2014.07.040. Epub 2014 Aug 7. Cancer Lett. 2014. PMID: 25109451

5

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.

Zhu X, Ying J, Wang F, Wang J, Yang H. Zhu X, et al. Breast Cancer Res Treat. 2014 Oct;147(3):551-5. doi: 10.1007/s10549-014-3136-y. Epub 2014 Sep 19. Breast Cancer Res Treat. 2014. PMID: 25234844

6

Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.

Zhu X, Shan L, Wang F, Wang J, Wang F, Shen G, Liu X, Wang B, Yuan Y, Ying J, Yang H. Zhu X, et al. Breast Cancer Res Treat. 2015 Apr;150(3):479-86. doi: 10.1007/s10549-015-3338-y. Epub 2015 Mar 18. Breast Cancer Res Treat. 2015. PMID: 25783183

7

[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].

Zhang Z, Wu X, Ying J, Li J, Qiu T, Guo H, Zhao H, Shan L, Ling Y. Zhang Z, et al. Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):199-205. doi: 10.3779/j.issn.1009-3419.2015.04.05. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25936883 Free PMC article. Chinese.

8

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Shan L, Wang Z, Guo L, Sun H, Qiu T, Ling Y, Li W, Li L, Liu X, Zheng B, Lu N, Ying J. Shan L, et al. Lung Cancer. 2015 Sep;89(3):337-42. doi: 10.1016/j.lungcan.2015.06.008. Epub 2015 Jun 19. Lung Cancer. 2015. PMID: 26141217

9

A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.

Yin X, Ying J, Li L, Zhang H, Wang H. Yin X, et al. Indian J Cancer. 2015 Nov;52 Suppl 1:e29-31. doi: 10.4103/0019-509X.168953. Indian J Cancer. 2015. PMID: 26548936 Free article.

10

Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Li W, Zhang Z, Guo L, Qiu T, Ling Y, Cao J, Guo H, Zhao H, Li L, Ying J. Li W, et al. Oncotarget. 2016 Feb 16;7(7):8332-40. doi: 10.18632/oncotarget.6671. Oncotarget. 2016. PMID: 26789109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters